| Investment Objective The objective of the scheme is to generate capital appreciation through arbitrage opportunities between cash and derivatives market and arbitrage opportunities within the derivative segment and by deployment of surplus cash in debt securities and money market instruments. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved. |
|
Date of inception/allotment |
22nd June, 2006 |
Fund Manager |
Mr. Sharwan Kumar Goyal - (Equity Portion) B.com, CFA, MMS. Managing the scheme since Dec 2020 Total Exp: 19 Yrs Mr. Amit Sharma - (Debt Portion) B.com, CA, FRM. Managing the scheme since Jul 2018 Total Exp: 17 Yrs |
Fund AUM/Folio as on 31st July, 2026 |
Fund Size Monthly Average : 11,322.08 Crore Closing AUM : 11,152.46 Crore No. of Folios : 22,282 |
High/Low NAV in the month |
High Growth Option : 37.3256 Low Growth Option : 37.1547 |
Month-end Total Expense Ratio (%)* |
Regular : 1.87 Direct : 1.29 *For detailed YTD Total Expense Ratio refer to Click Here |
Minimum Investment Amount |
Minimum initial investment of 5000/-and in multiples of 1/- thereafter with no upper limit. |
Plans/Options
(Regular / Direct) |
Growth Option IDCW Option with Payout and Reinvestment |
Load Structure |
Entry Load : Nil |
NAV per unit as on 31st July, 2026 |
Regular Growth Option 37.3256 Regular IDCW Option 21.0862 Direct Growth Option 39.9470 Direct IDCW Option 23.3672 |
Portfolio Parameters |
Weighted Average Maturity : 0.49 Yrs Yield to Maturity* : 6.89% Modified Duration : 0.48 Yrs Macaulay Duration : 0.48 Yrs *Annualized Portfolio YTM – Yields of all securities are annualized |
Benchmark Index |
Nifty 50 Arbitrage Index |
Portfolio |
% to NAV |
Hedged |
Equity |
66.83% |
|
MM Instruments |
32.86% |
|
STD |
0.40% |
|
Cash, MM & cash equivalent |
0.27% |
|
Total |
100.00 |
All figures given are provisional and unaudited.
Average Equity holding in UTI Arbitrage Fund is 71.08% for the past 12 months against the requirement of minimum 65% for equity taxation eligibility.
(Annual average of the monthly average opening and closing figures)
Quantitative Indicators |
Fund |
Benchmark |
Beta |
0.52 |
1 |
Standard Deviation (Annual) |
0.90% |
1.23% |
Sharpe ratio |
1.73 |
|
Portfolio Turnover Ratio (Annual) |
11.05 |
% of Top 10 Stocks |
0.02 |
Median Market Cap ( Cr) |
1,70,295 |
Weighted Average Market Cap |
4,30,723 |
Number of Securities |
137 |
| All figures given are provisional and unaudited. | |
UTI Arbitrage Fund (Formerly known as UTI Spread Fund) IDCW Declared - Last 10 Months IDCWs |
||||||
(Recent IDCWs)
|
||||||
Year |
IDCW |
Per unt |
NAV (Cum Div) |
Face Value (per unit) |
NAV Date |
Record Date |
2020 |
0.80% |
0.080 |
15.9591 |
10.00 |
29-06-2020 |
06-07-2020 |
2020 |
0.80% |
0.080 |
15.8805 |
10.00 |
29-07-2020 |
05-08-2020 |
2020 |
0.70% |
0.070 |
15.8518 |
10.00 |
31-08-2020 |
07-09-2020 |
2020 |
0.70% |
0.070 |
15.8206 |
10.00 |
29-10-2020 |
05-11-2020 |
2020 |
0.70% |
0.070 |
15.7670 |
10.00 |
27-11-2020 |
07-12-2020 |
2021 |
0.70% |
0.070 |
15.7462 |
10.00 |
30/12/2020 |
06/01/2021 |
2021 |
0.60% |
0.060 |
15.7017 |
10.00 |
01/02/2021 |
08/02/2021 |
2021 |
0.50% |
0.050 |
15.6864 |
10.00 |
01/03/2021 |
08/03/2021 |
2021 |
0.50% |
0.050 |
15.7097 |
10.00 |
31/03/2021 |
07/04/2021 |
2021 |
0.50% |
0.050 |
15.7253 |
10.00 |
03/05/2021 |
10/05/2021 |
2021 |
0.50% |
0.050 |
15.7461 |
10.00 |
31/05/2021 |
07/06/2021 |
2021 |
0.50% |
0.050 |
15.7642 |
10.00 |
30-06-2021 |
07-07-2021 |
2021 |
0.50% |
0.050 |
15.7656 |
10.00 |
02-08-2021 |
09-08-2021 |
2021 |
0.50% |
0.050 |
15.7694 |
10.00 |
01-09-2021 |
08-09-2021 |
| Fund Performance Vs Benchmark (CAGR) as on 31st July, 2026 Growth of 10000
|
||||||
| Period | NAV Growth (%) |
Nifty 50 Arbitrage TRI (%) |
CRISIL 1 Year T-Bill Index (%) |
NAV Growth () |
Nifty 50 Arbitrage TRI () |
CRISIL 1 Year T-Bill Index () |
| 1 Y | 5.97 | 7.31 | 4.21 | 10,597 | 10,731 | 10,421 |
| 3 Y | 6.96 | 7.56 | 6.32 | 12,239 | 12,446 | 12,020 |
| 5 Y | 6.05 | 6.53 | 5.67 | 13,416 | 13,723 | 13,177 |
| 10 Y | 5.79 | 5.63 | 5.97 | 17,562 | 17,298 | 17,864 |
| SI* | 6.77 | 6.36 | 6.15 | 37,361 | 34,577 | 33,229 |
Past performance may or may not be sustained in future. Different plans have a different expense structure. The performance details provided herein are of regular plan. The current fund manager is managing the scheme since Dec 2020 & July 2018. *Compounded annualized Growth Rate. Benchmark for UTI Arbitrage Fund has been changed from CRISIL Arbitrage Index to Nifty 50 Arbitrage Index. The Schemes is Managed by Mr. Sharwan Kumar Goyal & Mr. Amit Sharma. The performance of the benchmark is calculated using total return index variant of the benchmark index. Load is not taken into consideration for computation of performance.
| Period | |||||||
Investment Amount () |
Fund Value () |
Nifty 50 Arbitrage TRI Index () |
CRISIL 1 Year T-Bill Index () |
Yield (%) Fund |
Yield (%) Nifty 50 Arbitrage TRI Index |
Yield (%) CRISIL 1 Year T-Bill Index |
|
| 1 Y | 1,20,000 | 1,23,900 | 1,24,625 | 1,22,731 | 6.11 | 7.26 | 4.27 |
| 3 Y | 3,60,000 | 3,97,561 | 4,02,463 | 3,92,462 | 6.56 | 7.39 | 5.70 |
| 5 Y | 6,00,000 | 7,08,214 | 7,20,036 | 6,97,938 | 6.57 | 7.23 | 5.99 |
| 7 Y | 8,40,000 | 10,44,550 | 10,62,210 | 10,29,620 | 6.13 | 6.61 | 5.73 |
| 10 Y | 12,00,000 | 16,25,294 | 16,42,268 | 16,17,317 | 5.91 | 6.11 | 5.82 |
| 15 Y | 18,00,000 | 28,98,514 | 29,02,740 | 29,18,743 | 6.06 | 6.08 | 6.15 |
| SI | 24,00,000 | 47,38,352 | 45,16,672 | 46,60,868 | 6.35 | 5.92 | 6.20 |
Note: Systematic Investment Plan (SIP) returns are worked out assuming investment of 10,000/- every month at NAV per unit of the scheme as on the first working day for the respective time periods. The loads have not been taken into account. Past performance may or may not be sustained in future.
This product is suitable for investors who are seeking*:
- Capital appreciation over medium to long term
- Takes advantage of arbitrage opportunities in cash and derivative market without taking any directional/unhedged position in either equity or derivative instruments
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.